ロード中...
Surgical resection of lung adenocarcinoma after crizotinib treatment: report of a case
A 45-year-old female was diagnosed as having lung adenocarcinoma harboring an anaplastic lymphoma kinase (ALK) rearrangement, stage IV (T2bN3M1b). She was treated with crizotinib as second-line chemotherapy. The clinical stage after crizotinib treatment was ycT2aN0M0, stage IB. We performed a left l...
保存先:
| 出版年: | World J Surg Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4342155/ https://ncbi.nlm.nih.gov/pubmed/25889062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-015-0480-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|